Experts link Trump-era public health cuts to slower response in cyclospora outbreak

The United States is facing a cyclosporiasis outbreak that has infected more than 1,600 people, while experts warn that recent reductions in public-health resources have slowed detection and response. A spokesperson for the U.S. Department of Health and Human Services said the administration is maintaining a "robust response" and is working with state health departments to identify sources and inform the public.

Jennifer Nuzzo, director of the Pandemic Center at Brown University, noted that a 2025 change to the CDC’s FoodNet program removed cyclospora from its list of monitored pathogens, reducing focus on early detection. She said the change sent a signal to the broader system about the level of attention given to the disease. Nuzzo also highlighted that about 80% of CDC leadership positions are vacant, limiting the agency’s ability to alert states to emerging threats.

Jessica Steier, founder and CEO of Unbiased Science, said funding cuts did not cause the contamination but may have delayed understanding of the outbreak’s scope and public communication. Elisabeth Marnik of The Evidence Collective added that staffing and budget reductions likely weakened the overall response and that inconsistent federal and state case numbers created public confusion.

The CDC issued a health alert in mid-July reporting 1,645 confirmed cases and 5,100 pending analyses, but state reports, particularly from Michigan, suggested higher numbers. Experts criticized the lack of clear, timely messaging, saying it erodes public trust in federal health agencies.

Steier also pointed to long-standing resource constraints at the Food and Drug Administration, noting a 20% staff loss during the Trump administration and the disbanding of key advisory committees. Delays in implementing the Food Traceability Rule, which would have required detailed supply-chain records, were cited as further setbacks.

Overall, the experts interviewed argue that the combination of reduced funding, staffing gaps, and shifting federal priorities away from infectious-disease preparedness has left the United States less equipped to manage outbreaks such as cyclospora and the recent rise in measles cases.